acebutolol has been researched along with heptakis(2,6-o-dimethyl)beta-cyclodextrin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahsan, F; Arnold, JJ; Meezan, E; Pillion, DJ; Schwiebert, EM; Yang, T | 1 |
| Ahsan, F; Hussain, A; Yang, T; Zaghloul, AA | 1 |
| Ahsan, F; Bai, S; Mustafa, F; Yang, T | 1 |
3 other study(ies) available for acebutolol and heptakis(2,6-o-dimethyl)beta-cyclodextrin
| Article | Year |
|---|---|
Effects of the permeability enhancers, tetradecylmaltoside and dimethyl-beta-cyclodextrin, on insulin movement across human bronchial epithelial cells (16HBE14o-).
Topics: Adjuvants, Pharmaceutic; beta-Cyclodextrins; Biological Transport; Bronchi; Cells, Cultured; Cyclodextrins; Humans; Insulin; Maltose; Mannitol; Permeability; Respiratory Mucosa; Time Factors | 2003 |
Pulmonary absorption of insulin mediated by tetradecyl-beta-maltoside and dimethyl-beta-cyclodextrin.
Topics: Absorption; Adjuvants, Pharmaceutic; Animals; beta-Cyclodextrins; Biological Availability; Blood Glucose; Cyclodextrins; Instillation, Drug; Insulin; Lung; Male; Maltose; Rats; Rats, Sprague-Dawley; Respiratory Mucosa; Time Factors; Trachea | 2003 |
Pulmonary delivery of low molecular weight heparins.
Topics: Animals; Anticoagulants; beta-Cyclodextrins; Biological Transport, Active; Bronchi; Cell Line; Chemistry, Pharmaceutical; Dalteparin; Dose-Response Relationship, Drug; Drug Delivery Systems; Electric Conductivity; Enoxaparin; Epithelial Cells; Factor Xa; Heparin, Low-Molecular-Weight; Humans; Lung; Male; Maltose; Rats; Rats, Sprague-Dawley; United States | 2004 |